Xue Hu

2.9k total citations
47 papers, 624 citations indexed

About

Xue Hu is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Xue Hu has authored 47 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 17 papers in Hepatology and 16 papers in Molecular Biology. Recurrent topics in Xue Hu's work include Hepatitis B Virus Studies (17 papers), Hepatitis C virus research (13 papers) and Liver Disease Diagnosis and Treatment (9 papers). Xue Hu is often cited by papers focused on Hepatitis B Virus Studies (17 papers), Hepatitis C virus research (13 papers) and Liver Disease Diagnosis and Treatment (9 papers). Xue Hu collaborates with scholars based in China, Germany and United States. Xue Hu's co-authors include Xinwen Chen, Yuan Zhou, Chunchen Wu, Yun Wang, Jizheng Chen, Rongjuan Pei, Kaitao Zhao, Mengji Lu, Yifei Yuan and Rongjuan Pei and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Virology.

In The Last Decade

Xue Hu

44 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xue Hu China 16 318 225 155 99 73 47 624
Young-Mao Chen Taiwan 8 258 0.8× 186 0.8× 201 1.3× 290 2.9× 61 0.8× 16 736
Yu‐Chi Chou Taiwan 18 339 1.1× 272 1.2× 162 1.0× 109 1.1× 187 2.6× 55 851
Xue-Fei Cai China 16 438 1.4× 356 1.6× 193 1.2× 68 0.7× 79 1.1× 41 882
Shi Liu China 17 323 1.0× 351 1.6× 93 0.6× 250 2.5× 134 1.8× 35 791
Xiaoran Ding China 12 254 0.8× 181 0.8× 76 0.5× 115 1.2× 40 0.5× 21 494
Alexander Herrmann Germany 12 431 1.4× 242 1.1× 59 0.4× 62 0.6× 138 1.9× 25 829
Young‐Chan Kwon South Korea 14 233 0.7× 199 0.9× 102 0.7× 122 1.2× 269 3.7× 25 759
Guangyun Tan China 17 331 1.0× 356 1.6× 272 1.8× 385 3.9× 184 2.5× 30 962
Amir A. Ghaffari United States 8 308 1.0× 150 0.7× 58 0.4× 428 4.3× 101 1.4× 15 793
Xiaofang Cui China 14 237 0.7× 103 0.5× 54 0.3× 105 1.1× 66 0.9× 40 532

Countries citing papers authored by Xue Hu

Since Specialization
Citations

This map shows the geographic impact of Xue Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Hu more than expected).

Fields of papers citing papers by Xue Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Hu. The network helps show where Xue Hu may publish in the future.

Co-authorship network of co-authors of Xue Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Xue Hu. A scholar is included among the top collaborators of Xue Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue Hu. Xue Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Zhongwei, Xue Hu, Pingzheng Mo, et al.. (2025). Clinical characteristics and outcomes of disseminated intravascular coagulation in patients with severe fever with thrombocytopenia syndrome. BMC Infectious Diseases. 25(1). 508–508. 1 indexed citations
2.
Zhang, Xiaoyu, Xuekai Zhang, Jing Lü, et al.. (2025). The mRNA vaccine encoding Gc protein confers complete protection against severe fever with thrombocytopaenia syndrome virus. Vaccine. 63. 127631–127631. 1 indexed citations
3.
Li, Yapeng, et al.. (2024). An enhanced micro-PSO method to deal with asymmetric electricity markets competition within hydropower cascade. Applied Energy. 377. 124235–124235. 4 indexed citations
4.
Hu, Danqing, Peng Wang, Xiaojing Wang, et al.. (2024). The efficacy of antiviral treatment in chronic hepatitis B patients with hepatic steatosis. Heliyon. 10(7). e28653–e28653. 3 indexed citations
5.
Wu, Jiaming, et al.. (2024). Psychological experience of patients with postpartum depression: A qualitative meta-synthesis. PLoS ONE. 19(11). e0312996–e0312996. 2 indexed citations
6.
Ren, Wenlin, Yu Zhang, Ziyi Wang, et al.. (2023). Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant. mBio. 14(2). e0041623–e0041623. 11 indexed citations
7.
Hu, Danqing, Peng Wang, Xiaojing Wang, et al.. (2023). Disease severity and antiviral response in patients with chronic hepatitis B with non-obese NAFLD. Journal of the Formosan Medical Association. 123(7). 773–780. 1 indexed citations
8.
Yang, Bo, Yingshan Chen, Dan Huang, et al.. (2022). RNA-Binding motif protein 38 (RBM38) mediates HBV pgRNA packaging into the nucleocapsid. Antiviral Research. 198. 105249–105249. 8 indexed citations
9.
Zhang, Zhongwei, Zhongyuan Yang, Xue Hu, et al.. (2021). Establishment and validation of a prognostic model for hepatitis B virus‑related acute-on-chronic liver failure patients with bacterial infection. Hepatology International. 16(1). 38–47. 10 indexed citations
10.
Tang, Jielin, Qi Yang, He Zhao, et al.. (2020). Histone deacetylase 3 promotes innate antiviral immunity through deacetylation of TBK1. Protein & Cell. 12(4). 261–278. 29 indexed citations
11.
Li, Jing, Yifei Yuan, Yinan Zhao, et al.. (2020). Repurposing of Antazoline Hydrochloride as an Inhibitor of Hepatitis B Virus DNA Secretion. Virologica Sinica. 36(3). 501–509. 5 indexed citations
12.
Hu, Xue, Jing Li, Jingfang Mu, et al.. (2019). Major capsid protein of Autographa californica multiple nucleopolyhedrovirus contributes to the promoter activity of the very late viral genes. Virus Research. 273. 197758–197758. 8 indexed citations
13.
Yang, Qi, Min Guo, Yuan Zhou, et al.. (2019). Phosphatidylserine-Specific Phospholipase A1 is the Critical Bridge for Hepatitis C Virus Assembly. Virologica Sinica. 34(5). 521–537. 7 indexed citations
14.
Zhou, Ming, Kaitao Zhao, Yifei Yuan, et al.. (2017). Productive HBV infection of well-differentiated, hNTCP-expressing human hepatoma-derived (Huh7) cells. Virologica Sinica. 32(6). 465–475. 28 indexed citations
15.
Guo, Jing, Dan Chen, Xiaoxiao Gao, et al.. (2017). Protein Inhibitor of Activated STAT2 Restricts HCV Replication by Modulating Viral Proteins Degradation. Viruses. 9(10). 285–285. 14 indexed citations
16.
Gong, Yi, et al.. (2017). Elevated production of IL-36α in chronic hepatitis B virus-infected patients correlates with viral load. Microbial Pathogenesis. 113. 412–415. 9 indexed citations
17.
Mu, Jingfang, Yongli Zhang, Xue Hu, et al.. (2016). Autographa californica Multiple Nucleopolyhedrovirus Ac34 Protein Retains Cellular Actin-Related Protein 2/3 Complex in the Nucleus by Subversion of CRM1-Dependent Nuclear Export. PLoS Pathogens. 12(11). e1005994–e1005994. 16 indexed citations
18.
Wang, Yun, Yongli Zhang, Xue Hu, et al.. (2015). Identification of a Novel Regulatory Sequence of Actin Nucleation Promoting Factor Encoded by Autographa californica Multiple Nucleopolyhedrovirus. Journal of Biological Chemistry. 290(15). 9533–9541. 9 indexed citations
19.
Zhao, Kaitao, Shuhui Liu, Chunchen Wu, et al.. (2015). HBsAg sT123N mutation induces stronger antibody responses to HBsAg and HBcAg and accelerates in vivo HBsAg clearance. Virus Research. 210. 119–125. 11 indexed citations
20.
Hu, Xue. (2013). Research on the Teaching Model of Electronic Technology Experiment Flexibility.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Young-Mao Chen Breakdown of academic impact, for papers by Yu‐Chi Chou Breakdown of academic impact, for papers by Xue-Fei Cai Breakdown of academic impact, for papers by Shi Liu Breakdown of academic impact, for papers by Xiaoran Ding Breakdown of academic impact, for papers by Alexander Herrmann Breakdown of academic impact, for papers by Young‐Chan Kwon Breakdown of academic impact, for papers by Guangyun Tan Breakdown of academic impact, for papers by Amir A. Ghaffari Breakdown of academic impact, for papers by Xiaofang Cui
Rankless by CCL
2026